Agenus Inc. (AGEN) Discusses Financing and Robin Trial Strategy for Neoadjuvant Immunotherapy in MSS Colon Cancer – Slideshow Source link
TiumBio reports trial data for head and neck cancer drug Source link
Susie Wiles, White House chief of staff, in the Oval Office of the White House in Washington, June 27, 2025.
Austin, Texas, United States, February 9th, 2026, FinanceWire LIXTE Biotechnology Holdings (NASDAQ: LIXT), a clinical-stage pharmaceutical company, is leading efforts
Austin, Texas, United States, February 5th, 2026, FinanceWire LIXTE’s lead compound, LB-100, targets PP2A, a central regulator of cancer cell
Key Takeaways Abbott Laboratories has agreed to acquire Exact Sciences Corp. in a deal worth $21 billion, paying shareholders $105
Ideaya and Hengrui report promising data for DLL3-targeted cancer drug Source link
Congressman Gerry Connolly (D-VA) questions witnesses during a House Committee on Oversight and Government Reform hearing titled “A Hearing with
Pfizer signs up to $6 billion licensing deal with China's 3SBio for cancer drug Source link
Austin, Texas, United States, May 1st, 2025, FinanceWire TransCode Therapeutics (NASDAQ: RNAZ) reported continued progress in its Phase 1a trial
